Skip to content

Effect of low-dose esketamine added to etomidate on hypotension after general anesthesia induction in elderly patients undergoing percutaneous kyphoplasty

Effect of low-dose esketamine added to etomidate on hypotension after general anesthesia induction in elderly patients undergoing percutaneous kyphoplasty

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110874
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension after general anesthesia induction

Interventions

The esketamine group:Induction of anesthesia was achieved through intravenous injection of etomidate at a dose of 0.2mg/kg and esketamine at a dose of 0.2mg/kg.
The control group:Induction of anesthesia was achieved through intravenous injection of etomidate at a dose of 0.2mg/kg and normal saline.

Sponsors

The Fourth Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
75 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. patients scheduled for elective percutaneous vertebroplasty under general anaesthesia with tracheal intubation; 2. aged 75-90 years; 3. ASA II-III; 4. BMI 18-30 kg/m^2; 5. No history of cognitive impairment.

Exclusion criteria

Exclusion criteria: 1. hypersensitivity to any of the drugs used in the study; 2. uncontrolled hypertension (blood pressure > 180/100 mmHg at rest); 3. previous history of aneurysm/arteriovenous malformation; 4. Hyperthyroidism; 5. Severe cardiac disease (NYHA class III or IV; untreated or unstable ischaemic heart disease; history of severe aortic or mitral valve disease); 6. Severe hepatic impairment (Child-Pugh Class C); 7. severe renal impairment (undergoing renal replacement therapy); 8. history of previous psychiatric illness; 9. MAP <70 mmHg before induction of anaesthesia.

Design outcomes

Primary

MeasureTime frame
The area under the curve (AUC) of the change in mean arterial pressure (MAP) from baseline within 15 minutes after general anesthesia induction;

Secondary

MeasureTime frame
The incidence of hypotension within 15 minutes after general anesthesia induction;Maximum mean arterial pressure and heart rate;Minimum mean arterial pressure and heart rate;Cumulative number of phenylephrine;Cumulative dosage of phenylephrine;Time of disappearance of eyelash reflex ;Time of extubation;Recovery room stay time;Postoperative recovery quality score of the first day;Delirium;

Countries

China

Contacts

Public ContactChen Mo

The Fourth Affiliated Hospital of Soochow University

chenmo8058@163.com+86 138 1201 7729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026